We proudly point out that our service SRAclinic® is already used in more than 121 hospitals for the detection of paroxysmal atrial fibrillation.
In 2018 72.094 patients were examined, 10.540 patients were detected with atrial fibrillation by our automated algorithm. A risk was found in 16.446 patients.
News from England
New poster presentation as part of the UK Stroke Forum
New early atrial fibrillation (AF) detection by an automated
remote monitoring system on hyperacute stroke unit (HASU)
For the exclusive distribution in Switzerland apoplex medical technologies could win Leuag AG.
The medical technology specialist offers technically competent and efficient sales services for high-quality products for medicine and science and thus optimal conditions for synergies in the field of patient monitoring and cardiology.
We are looking forward to a successful cooperation!
apoplex medical technologies participates in Evina Spain SL
Evina Spain markets the SRA analysis method exclusively in Spain. The aim is to integrate SRA as an integral part of stroke prevention. Within the scope of this project, a multicenter study was conducted in which SRA found twice as many AF patients as in the current practice with ECG telemetry monitoring, and 3 times faster.
At the ESOC 2018 in Gothenburg, Prof. Davalos presented the study results to a specialist audience. The aim of this study is to establish a reimbursement for SRA in the Spanish health care system that would be unique in Europe and thus a good example of best practice.
On site, apoplex medical technologies will inform visitors about the possibilities of using SRA.
We look forward to your visit!
News January 2018
Review 2017
e proudly point out that our service SRAclinic® is already used in more than 80 hospitals for the detection of paroxysmal pre-slurries (pVHF).
In 2017 61.589 patients were examined, 9.728 patients were detected by our automated algorithm pVHF. In 14.919 patients, a risk was identified for VHF.
News November 2017
Congresses in November 2017
In November 2017, we are presenting ourselves together with partners in the countries of Italy and Brazil.
In Italy we are on November 3rd on the III ° CONVEGNO NEUROVASCOLARE DEL GARDA. In Brazil from November 3rd - 5th at the 72nd Brazilian Congress of Cardiology 2017.
News October 2017
New homepage from October 2017
Since October 2017, we are presenting ourselves with a new Internet presence!
All information about the company and the stroke risk analysis are presented, informative and presented in a new design.
News September 2017
DGN 2017 in Leipzig with apoplex medical technologies
from September 20 to 23, 2017
90th Congress of the German Society of Neurology
On site, apoplex medical technologies, together with the company Nihon Kohden, has informed visitors about the stroke risk analysis (SRA®).
Um unsere Webseite für Sie optimal zu gestalten und fortlaufend verbessern zu können, verwenden wir Cookies. Durch die weitere Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu.
